Uterine Closure for Cesarean Section: a Novel Technique
NCT ID: NCT05669300
Last Updated: 2022-12-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
360 participants
OBSERVATIONAL
2022-12-01
2022-12-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to describe the technique and compare the blood loss of patients in caserean section between Yılmaz technique and single layer continue locked suturation .
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Yilmaz Technique
the patients underwent ceserean section and uterus closed with Yilmaz Technique
Yilmaz Suturation
uterine closure with Yilmaz Technique and single layer continue locked suturation
single layer continue locked suturation
the patients underwent ceserean section and uterus closed with single layer continue locked suturation
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Yilmaz Suturation
uterine closure with Yilmaz Technique and single layer continue locked suturation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. singleton
2. alive fetus
Exclusion Criteria
1. uterine atonia,
2. coagulaopathy,
3. plasenta previa
4. blood transfusion -
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Recep Tayyip Erdogan University Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mehmet Kagitci
Assistant professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mehmet Kagitci
Rize, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022/178
Identifier Type: -
Identifier Source: org_study_id